"Mice, Inbred BALB C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research.
| Descriptor ID |
D008807
|
| MeSH Number(s) |
B01.050.050.199.520.520.338 B01.050.150.900.649.313.992.635.505.500.400.338
|
| Concept/Terms |
Mice, Inbred BALB C- Mice, Inbred BALB C
- BALB C Mouse, Inbred
- Inbred BALB C Mice
- Mouse, BALB C
- BALB C Mouse
- Mouse, Inbred BALB C
- Mice, BALB C
- BALB C Mice
- BALB C Mice, Inbred
- Inbred BALB C Mouse
|
Below are MeSH descriptors whose meaning is more general than "Mice, Inbred BALB C".
Below are MeSH descriptors whose meaning is more specific than "Mice, Inbred BALB C".
This graph shows the total number of publications written about "Mice, Inbred BALB C" by people in this website by year, and whether "Mice, Inbred BALB C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 8 | 8 |
| 1997 | 0 | 15 | 15 |
| 1998 | 0 | 11 | 11 |
| 1999 | 0 | 12 | 12 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 9 | 9 |
| 2002 | 0 | 24 | 24 |
| 2003 | 0 | 14 | 14 |
| 2004 | 1 | 15 | 16 |
| 2005 | 0 | 21 | 21 |
| 2006 | 0 | 18 | 18 |
| 2007 | 0 | 31 | 31 |
| 2008 | 0 | 18 | 18 |
| 2009 | 0 | 26 | 26 |
| 2010 | 0 | 29 | 29 |
| 2011 | 0 | 33 | 33 |
| 2012 | 0 | 26 | 26 |
| 2013 | 0 | 30 | 30 |
| 2014 | 0 | 25 | 25 |
| 2015 | 0 | 23 | 23 |
| 2016 | 0 | 36 | 36 |
| 2017 | 0 | 27 | 27 |
| 2018 | 0 | 44 | 44 |
| 2019 | 0 | 26 | 26 |
| 2020 | 0 | 35 | 35 |
| 2021 | 0 | 23 | 23 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 8 | 8 |
| 2024 | 2 | 13 | 15 |
| 2025 | 0 | 13 | 13 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice, Inbred BALB C" by people in Profiles.
-
Therapeutic potential of hookworm proteins in promoting regulatory immune responses to modulate Trypanosoma cruzi induced liver inflammation and oxidative stress. Mem Inst Oswaldo Cruz. 2026; 121:e250123.
-
Immunotherapy of TSA-1.C4 or in combination with BNZ confers protection against Trypanosoma cruzi infection with a distinct cytokine response. Vaccine. 2026 Mar 19; 76:128296.
-
Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice. J Virol. 2025 11 25; 99(11):e0140625.
-
Heterologous prime-pull mucosal vaccination with an adjuvanted RBD vaccine elicits robust IgA production and protects against SARS-CoV-2. Front Immunol. 2025; 16:1673460.
-
Bavachinin alleviates allergic rhinitis by modulating gut microbiota and inhibiting NLRP3-mediated epithelial pyroptosis through PI3K/AKT/NF-?B signaling pathway. Cell Signal. 2025 Nov; 135:112026.
-
SLC44A2 negatively regulates mitochondrial fatty acid oxidation to suppress colorectal progression by blocking the MUL1-CPT2 interaction. Cell Death Dis. 2025 Jul 01; 16(1):468.
-
Pan-H7 influenza human antibody virus neutralization depends on avidity and steric hindrance. JCI Insight. 2025 Jul 08; 10(13).
-
The effect of CTLA4-Ig on fibrotic progression in a murine model of chronic lung allograft dysfunction. J Heart Lung Transplant. 2025 Sep; 44(9):1504-1509.
-
Sugar Functionalized Collagen Material for Local Modulation of Innate Immunity. Adv Sci (Weinh). 2025 Aug; 12(31):e2415364.
-
Mucosal vaccines with STING-agonist liposomal formulations inhibit RSV (respiratory syncytial virus) replication in cotton rats. Vaccine. 2025 May 22; 56:127183.